AI assistant
Natco Pharma Ltd. — Call Transcript 2020
Nov 6, 2020
62741_rns_2020-11-06_3882f174-00ed-43a2-acfe-06020ed6407c.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [416 x 43] intentionally omitted <==
November 6, 2020
Corporate Relationship Department M/s. BSE Ltd Dalal Street, For, Mumbai 400001 Scrip Code: 52481
Manager – Listing M/s. National Stock Exchange of India Ltd “Exchange Plaza, Bandra Kurla Complex Bandra East, Mumbai 400051
Scrip Code: NATCOPHARM
Dear Sir
Sub: - Earning call for Q2 FY21
The Company will host an Earnings Call with Investors / Analysts at 11.00 a.m. IST on Friday, November 13, 2020 to disseminate Financial Results of the company for the quarter ended September 30, 2020.
A Copy of the same is enclosed for your ready reference
Thanking you
Yours faithfully For NATCO Pharma Limited
==> picture [107 x 22] intentionally omitted <==
M Adinarayana Company Secretary & Vice President (Legal & Corp Affairs)
==> picture [130 x 36] intentionally omitted <==
Axis House, C-2, Wadia International Centre, P.B Marg. Worli, Mumbai 400 025 (India)
==> picture [107 x 45] intentionally omitted <==
Natco Pharma
Q2FY21 Earnings Call on 13[th] November 2020 hosted by Axis Capital Limited
We are pleased to host, on behalf of Natco Pharma, a conference call for analysts and investors on Friday, 13[th] November 2020, following the announcement of financial results for the second quarter ended Sept 2020.
The call will be initiated with a brief management discussion on the Q2FY21 earnings performance followed by an interactive Question & Answer session. The management will be represented by:
-
Mr. Rajeev Nannapaneni : Vice Chairman and Chief Executive Officer
-
Mr. Rajesh Chebiyam : Vice President – Acquisitions, Institutional Investor Management and Corporate Communications
Details of conference call
| Date | : | Friday, 13thNovember 2020 |
|---|---|---|
| Time | : | 11:00 AM IST |
| Call leader | : | Mr. Prakash Agarwal, Axis Capital |
| Country | Dial-in |
|---|---|
| Primarynumber | +91 22 6280 1145/+ 91 22 7115 8046 |
| India local | +91 7045671221(available all over India) |
| International Dial-in | |
| - Hong Kong | 800 964 448 |
| - Singapore | 800 101 2045 |
| - U K | 0 808 101 1573 |
| - USA | 1 866 746 2133 |
Diamond pass registration – for pre registration
Copy this URL in your browser:
= https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber 9449178&linkSecurity String=1bee035c96
For further information please contact:
Prakash Agarwal
Dy Head – Research | Executive Director – Pharma Institutional Equity Research Axis Capital Limited Direct: +91 22 4325 1145 Board: +91 22 4325 2525 Mobile: +91 9820534334 Email: [email protected]